468 related articles for article (PubMed ID: 17701292)
1. Preparation and characterization of magnetic poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) microspheres.
Gou ML; Qian ZY; Wang H; Tang YB; Huang MJ; Kan B; Wen YJ; Dai M; Li XY; Gong CY; Tu MJ
J Mater Sci Mater Med; 2008 Mar; 19(3):1033-41. PubMed ID: 17701292
[TBL] [Abstract][Full Text] [Related]
2. Preparation of magnetic microspheres based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymers by modified solvent diffusion method.
Men K; Zeng S; Gou M; Guo G; Gu YC; Luo F; Zhao X; Wei Y; Qian Z
J Biomed Nanotechnol; 2010 Jun; 6(3):287-92. PubMed ID: 21179946
[TBL] [Abstract][Full Text] [Related]
3. Preparation of biodegradable polycaprolactone/poly (ethylene glycol)/polycaprolactone (PCEC) nanoparticles.
Jia W; Gu Y; Gou M; Dai M; Li X; Kan B; Yang J; Song Q; Wei Y; Qian Z
Drug Deliv; 2008 Sep; 15(7):409-16. PubMed ID: 18712617
[TBL] [Abstract][Full Text] [Related]
4. One-step preparation of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticles for plasmid DNA delivery.
Huang MJ; Gou ML; Qian ZY; Dai M; Li XY; Cao M; Wang K; Zhao J; Yang JL; Lu Y; Tu MJ; Wei YQ
J Biomed Mater Res A; 2008 Sep; 86(4):979-86. PubMed ID: 18067161
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the thermo- and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(ε-caprolactone).
Safaei Nikouei N; Lavasanifar A
Acta Biomater; 2011 Oct; 7(10):3708-18. PubMed ID: 21672641
[TBL] [Abstract][Full Text] [Related]
6. Mangiferin loaded magnetic PCEC microspheres: preparation, characterization and antitumor activity studies in vitro.
Xiao W; Hou J; Ma J; Yu B; Ren J; Jin W; Wu J; Zheng D; Fan K
Arch Pharm Res; 2021 Aug; 44(8):1-7. PubMed ID: 25266232
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system.
Zhou S; Deng X; Yang H
Biomaterials; 2003 Sep; 24(20):3563-70. PubMed ID: 12809785
[TBL] [Abstract][Full Text] [Related]
8. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
[TBL] [Abstract][Full Text] [Related]
9. Preparation of anti-CD40 antibody modified magnetic PCL-PEG-PCL microspheres.
Gao X; Kan B; Gou M; Zhang J; Guo G; Huang N; Zhao X; Qian Z
J Biomed Nanotechnol; 2011 Apr; 7(2):285-91. PubMed ID: 21702366
[TBL] [Abstract][Full Text] [Related]
10. Full factorial design optimization of anti-inflammatory drug release by PCL-PEG-PCL microspheres.
Azouz L; Dahmoune F; Rezgui F; G'Sell C
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():412-9. PubMed ID: 26478328
[TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted synthesis of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) tri-block co-polymers and use as matrices for sustained delivery of ibuprofen taken as model drug.
Yu Z; Liu L
J Biomater Sci Polym Ed; 2005; 16(8):957-71. PubMed ID: 16128231
[TBL] [Abstract][Full Text] [Related]
12. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
13. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
[TBL] [Abstract][Full Text] [Related]
15. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and release profiles of MPEG-PCL-MPEG microspheres containing immunoglobulin G.
Erdemli Ö; Usanmaz A; Keskin D; Tezcaner A
Colloids Surf B Biointerfaces; 2014 May; 117():487-96. PubMed ID: 24530344
[TBL] [Abstract][Full Text] [Related]
17. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
[TBL] [Abstract][Full Text] [Related]
18. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
19. Self-aggregation of cationically modified poly(ε-caprolactone)
Charoongchit P; Suksiriworapong J; Sripha K; Mao S; Sapin-Minet A; Maincent P; Junyaprasert VB
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():444-455. PubMed ID: 28024608
[TBL] [Abstract][Full Text] [Related]
20. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
